AbCellera Biologics Inc.

ABCL· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$12.63-0.79%

2026-09-18

Financials

Valuation Metrics

AbCellera Biologics Inc.'s Market Cap is $3.86B. At end of 2025 it was $1.02B. Ranked #1542 of 3,121 in US market (top 49%), #536 of 1,463 on NASDAQ (top 37%), #91 of 266 in Pharmaceuticals, Biotechnology & Life Sciences (top 34%) by Market Cap.

Investment Metrics(as of 2026-09-18)

Metric	Value	Rank
Size
Market Cap	$3.86B	US#1,542/3,121 Sec#91/266
Revenue	$66M	US#2,751/3,121 Sec#139/266
Net Income	$-165M	US—/3,121 Sec—/266
Total Assets	$1.31B	US#2,344/3,121 Sec#78/266
Net Assets	$896M	US#1,844/3,121 Sec#74/266
Value
P/B	4.30x	US#2,099/3,121 Sec#128/266
P/S	58.28x	US#2,926/3,121 Sec#167/266
FCF Yield	-3.68%	US—/3,121 Sec—/266
Profitability
ROE	-18.38%	US#2,468/3,121 Sec#96/266
ROA	-12.59%	US#2,707/3,121 Sec#107/266
Op. Margin	-340.25%	US#2,797/3,121 Sec#149/266
Revenue Growth	101.28%	US#97/3,121 Sec#35/266
Financial Health
Debt Ratio	45.93%	US#520/3,121 Sec#138/266
Total Debt	$136M	US#2,358/3,121 Sec#106/266
FCF	$-142M	US#2,705/3,121 Sec#172/266
Cash	$120M	US#2,100/3,121 Sec#157/266
Current Ratio	12.77x	US#196/3,121 Sec#62/266
Performance
1Y Return	167.58%	US#78/3,121 Sec#27/266
1M Return	5.16%	US#149/3,121 Sec#20/266
From 52W High	-4.17%	US#184/3,121 Sec#16/266
1Y MDD	-54.94%	US#2,632/3,121 Sec#200/266
Trading
Volume	5,176,183 shares	US#197/3,121 Sec#13/266
Trading Value	$65M	US#812/3,121 Sec#51/266
Per Share
EPS	$-0.54	US—/3,121 Sec—/266
BPS	$2.93	US#2,499/3,121 Sec#164/266